Live from the NIH registry
Studies recruiting near Davenport right now
Top 25 of 43 recruiting studies, sorted by proximity — each links to its official registry page
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
University of Iowa Health Care Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Revolution Medicines, Inc.
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Concept Medical Inc.
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Amgen
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Wake Forest University Health Sciences
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Vision Loss Night, Vision Disorders
Phase 3
Interventional 580 participants sought
Virdi Eye Clinic — Rock Island, Illinois (3.5 mi)
· Sponsor: Ocuphire Pharma, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Moline, Illinois (5.8 mi)
· Sponsor: GlaxoSmithKline
EVERO Drug-coated Balloon (DCB) Randomized Trial
Peripheral Vascular Disease, Peripheral Arterial Disease
N/A
Interventional 410 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Cook Research Incorporated
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Moline, Illinois (5.8 mi)
· Sponsor: AstraZeneca
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC)
Phase 3
Interventional 1,040 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Genesis Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: Stryker Instruments
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
MidValley Research, Inc — Moline, Illinois (5.8 mi)
· Sponsor: Pfizer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
IC-8 Apthera IOL New Enrollment Post Approval Study
Cataract, Presbyopia
N/A
Observational 435 participants sought
Virdi Eye Clinic and Laser Vision Center — Rock Island, Illinois (3.5 mi)
· Sponsor: Bausch & Lomb Incorporated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The Fourth Left Atrial Appendage Occlusion Study
Atrial Fibrillation, Stroke, Ischemic
N/A
Interventional 4,000 participants sought
Cardiovascular Medicine, PLLC and Unity Point Trinity Rock Island — Rock Island, Illinois (3.5 mi)
· Sponsor: Hamilton Health Sciences Corporation
AcoArt Litos PCB Below-the-knee Global Trial
Chronic Limb-Threatening Ischemia
N/A
Interventional 288 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Acotec Scientific Co., Ltd